Phase I/II, open label, multicenter, study of rapcabtagene autoleucelin adult patients with CLL/SLL, 3L+ DLBCL, ALL and 1L HR LBCL

  • Fleming, Shaun (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date7/12/21 → 31/12/25

Keywords

  • Malignant Haematology
  • Clinical trial